Covered recipient · General Payments record
ESSAM K NAGORI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2023
$650.53
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $366.88 | 7 |
| Consulting Fee | $200.00 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $200.00 | 1 |
| Inari Medical, Inc. | $160.65 | 2 |
| Shionogi Inc | $111.10 | 1 |
| United Therapeutics Corporation | $47.30 | 2 |
| GlaxoSmithKline, LLC. | $24.58 | 1 |
| La Jolla Pharmaceutical Company | $23.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $200.00 | 10/25/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1000391545 | CMS |
| GlaxoSmithKline, LLC. | $24.58 | 08/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003487655 | CMS |
| Inari Medical, Inc. | $60.00 | 02/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057845431 | CMS |
| Inari Medical, Inc. | $100.65 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1057845435 | CMS |
| La Jolla Pharmaceutical Company | $23.25 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1039436291 | CMS |
| Shionogi Inc | $111.10 | 10/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1051745413 | CMS |
| United Therapeutics Corporation | $21.07 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050954629 | CMS |
| United Therapeutics Corporation | $26.23 | 06/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050960445 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.